VEXAS SYNDOME
Clinical trials for VEXAS SYNDOME explained in plain language.
Never miss a new study
Get alerted when new VEXAS SYNDOME trials appear
Sign up with your email to follow new studies for VEXAS SYNDOME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hope for rare inflammatory VEXAS syndrome
Disease control Recruiting nowThis phase 2 trial tests the drug momelotinib in 57 people with VEXAS syndrome, a rare inflammatory condition that may also involve a bone marrow disorder called MDS. Participants receive momelotinib daily, and doctors check if symptoms improve and if steroid doses can be lowered…
Matched conditions: VEXAS SYNDOME
Phase: PHASE2 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Genetic hunt for hidden causes of mysterious inflammatory diseases
Knowledge-focused Recruiting nowThis study aims to better understand VEXAS syndrome and other autoinflammatory conditions by analyzing participants' DNA from blood, saliva, or skin samples. Researchers hope to discover new genetic variants that cause or contribute to these diseases. The study enrolls people of …
Matched conditions: VEXAS SYNDOME
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC